Biomx Inc (PHGE) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NYSE MKT

Key Metrics

• Price: $4.56
• Market Cap: $7.31M
• EPS: $-37.05
• 52-Week High: $14.63
• 52-Week Low: $1.50

Market Sentiment

Biomx Inc currently has a Bearish sentiment score of -0.70.

About Biomx Inc

BiomX Inc. (PHGE) is an innovative clinical-stage microbiome therapeutics company based in Ness Ziona, Israel, specializing in harnessing both natural and engineered phage technologies to tackle pathogenic bacterial infections. The company is committed to addressing chronic diseases associated with dysbiosis, developing a proprietary pipeline of advanced therapies aimed at treating conditions such as inflammatory bowel disease, cystic fibrosis, and acne. With a focus on delivering transformat...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Biomx Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PHGE pay dividends?

Biomx Inc (PHGE) does not currently pay a regular dividend.

What is PHGE's market cap?

Biomx Inc (PHGE) has a market capitalization of $7.31M with a current stock price of $4.56.